<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prognosis of adults with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is very poor and depends on initial <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> and/or bone marrow involvement </plain></SENT>
<SENT sid="1" pm="."><plain>We report results in nine adult patients with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> (n = 9) and/or bone marrow involvement (n = 7) treated in first complete remission (CR) with allogeneic bone marrow transplantation (BMT) </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> treatment before the conditioning regimen consisted of cranial irradiation at 15 Gy (n = 8) and intrathecal chemotherapy (n = 9) </plain></SENT>
<SENT sid="3" pm="."><plain>The conditioning regimen included <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and total body irradiation (TBI) in a single dose </plain></SENT>
<SENT sid="4" pm="."><plain>No postgraft <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> prophylaxis was administered </plain></SENT>
<SENT sid="5" pm="."><plain>At the present time, seven patients are alive and disease-free at 18, 23, 44, 47, 54, 54, and 59 months </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients died at 14 and 7 months from transfusion-related acquired <z:hpo ids='HP_0002721'>immune deficiency</z:hpo> syndrome and <z:mp ids='MP_0001794'>bacterial</z:mp> <z:mpath ids='MPATH_681'>septicemia</z:mpath> and were disease-free at the time of their <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>These preliminary results should encourage the use of BMT </plain></SENT>
<SENT sid="8" pm="."><plain>A prospective randomized trial is warranted to further specify and investigate the advantages of allogeneic BMT versus conventional chemotherapy </plain></SENT>
</text></document>